{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:22:12Z","timestamp":1789381332336,"version":"build-2803163510"},"reference-count":38,"publisher":"American Diabetes Association","issue":"4","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,4,1]]},"abstract":"<jats:p>The use of HIV protease inhibitors (PIs) has been associated with several metabolic changes, including lipodystrophy, hyperlipidemia, and insulin resistance. The etiology of these adverse effects remains unknown. PIs have recently been found to cause acute and reversible inhibition of GLUT4 activity in vitro. To determine the acute in vivo effects of indinavir on whole-body glucose homeostasis, glucose tolerance tests were performed on PI-nai\u0308ve Wistar rats immediately after a single intravenous dose of indinavir. Glucose and insulin levels were significantly elevated in indinavir-treated versus control rats (P &amp;lt; 0.05) during the initial 30 min of the glucose tolerance test. Under euglycemic- hyperinsulinemic clamp conditions, indinavir treatment acutely reduced the glucose infusion rate required to maintain euglycemia by 18 and 49% at indinavir concentrations of 14 and 27 \u03bcmol\/l, respectively. Muscle 2-deoxyglucose uptake was similarly reduced under these conditions. Restoration of insulin sensitivity was observed within 4 h after stopping the indinavir infusion. Indinavir did not alter the suppression of hepatic glucose output under hyperinsulinemic conditions. These data demonstrate that indinavir causes acute and reversible changes in whole-body glucose homeostasis in rats and support the contribution of GLUT4 inhibition to the development of insulin resistance in patients treated with PIs.<\/jats:p>","DOI":"10.2337\/diabetes.51.4.937","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"937-942","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":79,"title":["Indinavir Induces Acute and Reversible Peripheral Insulin Resistance in Rats"],"prefix":"10.2337","volume":"51","author":[{"given":"Paul W.","family":"Hruz","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri"},{"name":"Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Murata","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Mueckler","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031223003360700_R1","doi-asserted-by":"crossref","unstructured":"Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med\u2008338:853\u2013860,1998","DOI":"10.1056\/NEJM199803263381301"},{"key":"2022031223003360700_R2","doi-asserted-by":"crossref","unstructured":"Carr A, Samaras K, Burton S, Law M, Freund I, Chisholm DJ, Cooper DA: A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS\u200812:F51\u2013F58,1998","DOI":"10.1097\/00002030-199807000-00003"},{"key":"2022031223003360700_R3","doi-asserted-by":"crossref","unstructured":"Hruz PW, Murata H, Mueckler M: Adverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanism. Am J Physiol\u2008280:E549\u2013E553,2001","DOI":"10.1152\/ajpendo.2001.280.4.E549"},{"key":"2022031223003360700_R4","doi-asserted-by":"crossref","unstructured":"Murata H, Hruz PW, Mueckler M: The mechanism of insulin resistance caused by HIV protease inhibitor therapy. J Biol Chem\u2008275:20251\u201320254,2000","DOI":"10.1074\/jbc.C000228200"},{"key":"2022031223003360700_R5","doi-asserted-by":"crossref","unstructured":"Marshall BA, Ren JM, Johnson DW, Gibbs EM, Lillquist JS, Soeller WC, Holloszy JO, Mueckler M: Germline manipulation of glucose homeostasis via alteration of glucose transporter levels in skeletal muscle. J Biol Chem\u2008268:18442\u201318445,1993","DOI":"10.1016\/S0021-9258(17)46645-2"},{"key":"2022031223003360700_R6","doi-asserted-by":"crossref","unstructured":"Ren JM, Marshall BA, Gulve EA, Gao J, Johnson DW, Holloszy JO, Mueckler M: Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle. J Biol Chem\u2008268:16113\u201316115,1993","DOI":"10.1016\/S0021-9258(19)85395-4"},{"key":"2022031223003360700_R7","doi-asserted-by":"crossref","unstructured":"Marshall BA, Hansen PA, Ensor NJ, Ogden MA, Mueckler M: GLUT-1 or GLUT-4 transgenes in obese mice improve glucose tolerance but do not prevent insulin resistance. Am J Physiol\u2008279:E390\u2013E400,1999","DOI":"10.1152\/ajpendo.1999.276.2.E390"},{"key":"2022031223003360700_R8","doi-asserted-by":"crossref","unstructured":"Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, Shulman GI: Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med\u2008341:240\u2013246,1999","DOI":"10.1056\/NEJM199907223410404"},{"key":"2022031223003360700_R9","doi-asserted-by":"crossref","unstructured":"James DE, Strube M, Mueckler M: Molecular cloning and characterization of an insulin-regulatable glucose. Nature\u2008338:83\u201387,1989","DOI":"10.1038\/338083a0"},{"key":"2022031223003360700_R10","doi-asserted-by":"crossref","unstructured":"Birnbaum MJ: Identification of a novel gene encoding an insulin-responsive glucose transporter protein. Cell\u200857:305\u2013315,1989","DOI":"10.1016\/0092-8674(89)90968-9"},{"key":"2022031223003360700_R11","doi-asserted-by":"crossref","unstructured":"Charron MJ, Brosius FD, Alper SL, Lodish HF: A glucose transport protein expressed predominately in insulin-responsive tissues. Proc Natl Acad Sci U S A\u200886:2535\u20132539,1989","DOI":"10.1073\/pnas.86.8.2535"},{"key":"2022031223003360700_R12","doi-asserted-by":"crossref","unstructured":"Kaestner KH, Christy RJ, McLenithan JC, Braiterman LT, Cornelius P, Pekala PH, Lane MD: Sequence, tissue distribution, and differential expression of mRNA for a putative insulin-responsive glucose transporter in mouse 3T3-L1 adipocytes. Proc Natl Acad Sci U S A\u200886:3150\u20133154,1989","DOI":"10.1073\/pnas.86.9.3150"},{"key":"2022031223003360700_R13","doi-asserted-by":"crossref","unstructured":"Mulligan K, Grunfeld C, Tai VW, Algren H, Pang M, Chernoff DN, Lo JC, Schambelan M: Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndr\u200823:35\u201343,2000","DOI":"10.1097\/00042560-200001010-00005"},{"key":"2022031223003360700_R14","doi-asserted-by":"crossref","unstructured":"Behrens G, Dejam A, Schmidt H, Balks H, Brabant G, Korner T, Stoll M, Schmidt R: Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS\u200813:F63\u2013F70,1999","DOI":"10.1097\/00002030-199907090-00001"},{"key":"2022031223003360700_R15","doi-asserted-by":"crossref","unstructured":"Yarasheki KE, Tebas P, Sigmund C, Dagogo-Jack S, Bohrer A, Turk J, Halban P, Cryer PE, Powderly WG: Insulin resistance in HIV protease inhibitor-associated diabetes. J Acquir Immune Defic Syndr\u200821:209\u2013216,1999","DOI":"10.1097\/00126334-199907010-00005"},{"key":"2022031223003360700_R16","doi-asserted-by":"crossref","unstructured":"Noor M, Lo JC, Mulligan K, Schwarz JM, Halvorsen R, Shambelan M, Grunfeld C: Metabolic effects of indinavir in healthy HIV-seronegative subjects. AIDS\u200815:11\u201318,2001","DOI":"10.1097\/00002030-200105040-00001"},{"key":"2022031223003360700_R17","doi-asserted-by":"crossref","unstructured":"Foisy ML, Sommadossi JP: Rapid quantification of indinavir in human plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Appl\u2008721:239\u2013247,1999","DOI":"10.1016\/S0378-4347(98)00451-4"},{"key":"2022031223003360700_R18","doi-asserted-by":"crossref","unstructured":"Morgan C, Lazaro A: Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes\u200812:115\u2013126,1963","DOI":"10.2337\/diab.12.2.115"},{"key":"2022031223003360700_R19","doi-asserted-by":"crossref","unstructured":"Kraegen EW, James DE, Bennett SP, Chisholm DJ: In vivo insulin sensitivity in the rat determined by euglycemic clamp. Am J Physiol\u2008245:E1\u2013E7,1983","DOI":"10.1152\/ajpendo.1983.245.1.E1"},{"key":"2022031223003360700_R20","doi-asserted-by":"crossref","unstructured":"Hom FG, Goodner CJ, Berrie MA: A [3H]2-deoxyglucose method for comparing rates of glucose metabolism and insulin responses among rat tissues in vivo: validation of the model and the absence of an insulin effect on brain. Diabetes\u200833:141\u2013152,1984","DOI":"10.2337\/diabetes.33.2.141"},{"key":"2022031223003360700_R21","doi-asserted-by":"crossref","unstructured":"Smith D, Rossetti L, Ferrannini E, Johnson CM, Cobelli C, Toffolo G, Katz LD, DeFronzo RA: In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies. Metabolism\u200836:1167\u20131174,1987","DOI":"10.1016\/0026-0495(87)90244-7"},{"key":"2022031223003360700_R22","doi-asserted-by":"crossref","unstructured":"Anderson PL, Brundage RC, Bushman L, Kakuda TN, Remmel RP, Fletcher CV: Indinavir plasma protein binding in HIV-1-infected adults. AIDS\u200814:2293\u20132297,2000","DOI":"10.1097\/00002030-200010200-00010"},{"key":"2022031223003360700_R23","unstructured":"Lin JH, Chiba M, Balani SK, Chen I, Kwei GY, Vastag KJ, Nishime JA: Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor. Drug Metab Dispos\u200824:1111\u20131120,1996"},{"key":"2022031223003360700_R24","doi-asserted-by":"crossref","unstructured":"Kraegen EW, James DE, Jenkins AB, Chisholm DJ: Dose response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol\u2008248:E353\u2013E362,1985","DOI":"10.1152\/ajpendo.1985.248.3.E353"},{"key":"2022031223003360700_R25","doi-asserted-by":"crossref","unstructured":"Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI: Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest\u200897:2859\u20132865,1996","DOI":"10.1172\/JCI118742"},{"key":"2022031223003360700_R26","doi-asserted-by":"crossref","unstructured":"Dube MP: Disorders of glucose metabolism in patients infected with human immunodeficiency virus. Clin Infect Dis\u200831:1467\u20131475,2000","DOI":"10.1086\/317491"},{"key":"2022031223003360700_R27","doi-asserted-by":"crossref","unstructured":"Lenhard JM, Croom DK, Weiel JE, Spaltenstein A, Reynolds DJ, Furfine ES: Dietary fat alters HIV protease inhibitor-induced metabolic changes in mice. J Nutr\u2008130:2361\u20132366,2000","DOI":"10.1093\/jn\/130.9.2361"},{"key":"2022031223003360700_R28","unstructured":"Ye JM, Samaras K, Bonner KM, Cooney GJ, Chisholm DJ, Kraegen EW: Ritonovir has paradoxical effects on lipid metabolism and insulin sensitivity in rats compared with humans. AIDS\u200812:2236\u20132237,1998"},{"key":"2022031223003360700_R29","unstructured":"Kalmanovich M, Brun RP, Kohlbrenner W: The presence of serum \u03b11-acid glycoprotein diminishes the inhibition of insulin-stimulated DOG uptake by HIV protease inhibitors (Abstract). Diabetes\u200850:A505,2001"},{"key":"2022031223003360700_R30","doi-asserted-by":"crossref","unstructured":"Weyer C, Bogardus C, Pratley RE: Metabolic characteristics of individuals with impaired fasting glucose and\/or impaired glucose tolerance. Diabetes\u200848:2197\u20132203,1999","DOI":"10.2337\/diabetes.48.11.2197"},{"key":"2022031223003360700_R31","unstructured":"Merck: Crivixan (indinavir sulfate) capsules product monograph. Whitehouse Station, NJ, Merck,1997 (monogr. no. 7979822)"},{"key":"2022031223003360700_R32","doi-asserted-by":"crossref","unstructured":"Nolte LA, Yarasheski KE, Kawanaka K, Fisher J, Le N, Holloszy JO: The HIV protease inhibitor indinavir decreases insulin- and contraction-stimulated glucose transport in skeletal muscle. Diabetes\u200850:1397\u20131401,2001","DOI":"10.2337\/diabetes.50.6.1397"},{"key":"2022031223003360700_R33","doi-asserted-by":"crossref","unstructured":"Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, Kahn BB: Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature\u2008409:729\u2013733,2001","DOI":"10.1038\/35055575"},{"key":"2022031223003360700_R34","doi-asserted-by":"crossref","unstructured":"Madge S, Kinloch-de-Loes S, Mercey D, Johnson MA, Weller IV: Lipodystrophy in patients naive to HIV protease inhibitors (Letter). AIDS\u200813:735\u2013737,1999","DOI":"10.1097\/00002030-199904160-00020"},{"key":"2022031223003360700_R35","doi-asserted-by":"crossref","unstructured":"Saint-Marc T, Partisani M, Poizot-Martin I, Bruno F, Rouviere O, Lang J, Gastaut J, Touraine J: A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS\u200813:1659\u20131667,1999","DOI":"10.1097\/00002030-199909100-00009"},{"key":"2022031223003360700_R36","doi-asserted-by":"crossref","unstructured":"Mallal SA, John M, Moore CB, James IR, McKinnon EJ: Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS\u200814:1309\u20131316,2000","DOI":"10.1097\/00002030-200007070-00002"},{"key":"2022031223003360700_R37","doi-asserted-by":"crossref","unstructured":"Mohamed-Ali V, Pinkney JH, Coppack SW: Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord\u200822:1145\u20131158,1998","DOI":"10.1038\/sj.ijo.0800770"},{"key":"2022031223003360700_R38","doi-asserted-by":"crossref","unstructured":"Ahima RS, Flier JS: Adipose tissue as an endocrine organ. Trends Endo Metab\u200811:327\u2013332,2000","DOI":"10.1016\/S1043-2760(00)00301-5"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/51\/4\/937\/661777\/db0402000937.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/51\/4\/937\/661777\/db0402000937.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:13:44Z","timestamp":1667405624000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/51\/4\/937\/34625\/Indinavir-Induces-Acute-and-Reversible-Peripheral"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4,1]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.51.4.937","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4,1]]}}}